Bluebird bio Inc
Biotechnology
Healthcare
BLUE
194 M shares
NASDAQ US
traded
30 May 2025
listed
no
open
4.74
52 week high
14.73
high
5.03
52 week low
3.29
low
4.67
growth
-75.06 %
previous Close
4.97
P/E ratio
market cap
74.47 M
div yield
0
usd
Sep 2024
qoq
revenue
10.61 M
-34.09 %
net incoming
-60.81 M
25.29 %
eps
0.00 %
96.31 %
eps surprise
13.89 %
net profit margin
-573.01 %
-67.00 %
operating incoming
-66.92 M
24.29 %
net change in cash
-74.57 M
-5.48 %
cash on hand
70.65 M
-50.96 %
cost of revenue
11.78 M
-59.30 %
top top